Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.09 CAD | -0.95% | -0.95% | -22.96% |
04-17 | NervGen Reports FY 2023 Net Loss of $0.38 Per Share, Provides Operations Update | MT |
04-17 | NervGen Pharma Corp. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Official Publications
No official publication found
- Stock Market
- Equities
- NGEN Stock
- News NervGen Pharma Corp.
- Official Publications